Infection Control Market

Report Overview

The global infection control market was pegged at US$ 215.34 billion in 2021 and is expected to witness a CAGR of 6.5% during the forecast period.

Market Fundamental 

Microorganisms such as viruses, bacteria, fungi, and parasites are mostly responsible for infections. Infections can range from stomach and intestinal infections to lung and respiratory infections, eye and ear infections, hospital-acquired infections (HAIs), skin infections, and sexually transmitted infections. Cross-infection from the surface and skin of the patient, equipment, and healthcare staff can cause these illnesses. The expanding number of surgical procedures, the need to lower the risk of Hospital Acquired Infections (HAI), and a growing emphasis on food sterilization are significant factors driving the worldwide infection control market. Both patients and healthcare providers are concerned about HAIs. According to estimates, 1.7 million hospital-acquired illnesses occur each year, and about 100,000 of these cases result in death. Infection-causing bacteria, fungi, and viruses are frequently exposed to healthcare personnel. 

Infections can develop during four frequent healthcare procedures: surgery, catheter insertion, and injections; as well as catheter-associated urinary tract infections and pneumonia induced by ventilators. Furthermore, the rising frequency of HAIs and infectious virus-related disorders is boosting demand for infection control strategies. Technological improvement and public awareness have contributed to an increase in surgical procedures, which has led to an increase in infection control demand. Surgical site infections (SSI) in surgery patients accounted for 14% to 17% of all hospital-acquired infections and 38% of all nosocomial infections. According to 2019 data, nearly 1.84 million procedures were performed in recognized hospitals in the United States. 

Furthermore, infections caused by germs or bacteria necessitate proper sanitation. Surgical tools and equipment must be sterilized and disinfected to decrease disease transmission; hence, infection control measures are required to reduce infection transmission among patients and hospital staff. Furthermore, infections connected with health care significantly burden patients, society, and health care administration. The advent of life-threatening infections such as SARS and re-emerging infectious diseases such as plague and tuberculosis has underlined the need for effective infection control programs in all healthcare settings and capacity building for healthcare personnel. An infection control program is effective when it limits infection transmission among hospital patients and employees. A good infection control program also significantly reduces patients' morbidity and mortality, length of hospital stays, and hospital costs.

[6744564]

Market Dynamics 

The major factors driving the global infection control market are an increase in the incidence of hospital-acquired infections, an increase in the number of surgical procedures that require high-intensity infection prevention and control, a growth in the number of government awareness programs to ensure a high degree infection prevention, augmenting geriatric population, and chronic diseases such as diabetes, obesity, cancer, heart, and respiratory disorders. Furthermore, an increase in the need for sterilization and disinfection in hospitals and clinics, technological advancements in related equipment, outsourcing of sterilization services among hospitals, pharmaceutical and medical device companies, and growth in the production of medical nonwovens and single-use products due to COVID-19 pandemic are expected to drive the growth of the infection control market. Additionally, a rising number of comprehensive infection prevention and control training modules for nurses and other medical workers is expected to increase the potential for widespread use of infection control products in the next years. For instance, the College of Nurses of Ontario issued guidelines on standard procedures, focusing on maintaining hand cleanliness to avoid contamination and infection spread. Furthermore, the Centers for Disease Control and Prevention (CDC) has issued disinfection and sterilization guidelines for the effective use of infection control products by healthcare staff in various settings, including ambulatory care, home care, hospitals, and others.

Market Ecosystem 

The global infection control market has been analyzed from three perspectives: Product, End user, and Region. 

Infection Control Market by Product

[85646334]

Based on products, the global infection control market has been segmented into sterilization, disinfection, endoscope reprocessing, and protective barriers. The sterilization market includes steam, radiation, sterilant, and indicators products. The disinfection products are also segmented into washers, UV disinfection, and disinfectants. The sterilization segment dominated the market during the forecast period. Sterilization is essential for controlling infectious diseases that may exist throughout hospitals or healthcare facilities, and it is debatable whether antibiotics can manage such a widespread attack.

Infection Control Market by End User

Based on end users, the global infection control market has been segmented into hospitals & clinics, pharmaceutical & medical device companies, and others. The hospitals & clinics dominated the market due to the high volume of surgical procedures performed in hospitals, greater incidence of hospital-acquired infections (HAIs), and proliferation in the number of hospitals and clinics. The increase in the geriatric population and chronic disease prevalence further supports this. Additionally, the segment expansion can be attributed to the rising demand for contagious diseases management, such as COVID-19, and the subsequent need for disposable infection control supplies such as face masks, gloves, surgical gowns, personal protective equipment (PPEs) etc.

Infection Control Market by Region 

Based on region, the global infection control market has been segmented into North America, Europe, Asia Pacific, Rest of the World. North America dominated the region during the forecast period. The market growth prospect can be attributed to the high reception of cleaning and sanitization solutions alongside administrations due to the rising emphasis on healthy living and sickness prevention among clients. The aging population and proportionate increase in chronic illness prevalence, the need for infection control to limit the spread of HAIs, and the implementation of positive government campaigns and stringent guidelines on sanitization and sterilization are all driving the infection control market in North America.

The infection control market is expected to grow at the fastest CAGR during the forecast period, owing to the growing presence of rethinking associations, growing medical services consumption, and remarkable medical care guidelines and foundation advancement across this sector. The presence of several deliberate and government associations focused on further developing disease control rules is also one of the major factors contributing to the development of the Asia Pacific region. The expanding pattern of re-appropriation by established market participants in developed economies to organizations in the Asia Pacific region also serves as a significant development-stimulating driver for the industry.

Competitive Landscape 

Some of the prominent market players in the global infection control market include 

• 3M Company
• Belimed AG
• Halyard Health, Inc.
• Getinge Group
• Cantel Medical Corporation
• Advanced Sterilization Products
• Matchana Group
• Reckitt Benckiser
• Sterigenics International
• MMM Group
• Honeywell International, Inc.
• Cantel Medical Corporation
• STERIS Corporation
• Ecolab

The global infection control market is competitive and moderately fragmented. Industry players focus on new product releases, product developments, and regional expansion to increase their market share.

Strategic Development 

• In September 2022, 3M Company declared the completion of both the split-off exchange offer for 3M common shares and the merger of Garden SpinCo Corporation ("SpinCo"), the 3M subsidiary owning the food safety business, with a subsidiary of Neogen Corporation ("Neogen"). SpinCo is currently owned entirely by Neogen.
• In June 2022, Belimed AG acquired Amity International, a specialized chemical company in the United Kingdom. During the last three decades, Amity has developed a specialized assortment of chemicals, supplies, and machinery for the worldwide healthcare business.
• In November 2021, STERIS announced an agreement to acquire Cantel, a global supplier of contamination anticipation goods and administrations, through a U.S. subsidiary, to widen its vast assortment of disease control items and administrations.
• In August 2021, Advanced Sterilization Products, a Fortive company, introduced the STERRAD VELOCITY, a biological Indicator (BI)/process challenge device (PCD).

Frequently Asked Questions About This Report